Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behavioral depression: thyroid interactions with norepinephrine-depleting drugs.

J W Davenport, R S Hennies, J C Carey

    Pharmacology, Biochemistry, and Behavior
    |July 1, 1976
    PubMed
    Summary

    Triiodothyronine (T3) treatment synergistically enhanced the behavioral depression caused by dopamine beta-hydroxylase inhibitor FLA-63 in rats. This potentiation suggests increased FLA-63 toxicity in hyperthyroid states.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anthropocene survival of southern New England's salt marshes.

    Estuaries and coasts : journal of the Estuarine Research Federation·2018
    Same author

    Contrasting decadal-scale changes in elevation and vegetation in two Long Island Sound salt marshes.

    Estuaries and coasts : journal of the Estuarine Research Federation·2018
    Same author

    Author Correction: Crowther et al. reply.

    Nature·2018
    Same author

    Crowther et al. reply.

    Nature·2018
    Same author

    Quantifying global soil carbon losses in response to warming.

    Nature·2016
    Same author

    Bone resorption in syndromes of the Ras/MAPK pathway.

    Clinical genetics·2011

    Area of Science:

    • Neuropharmacology
    • Endocrinology
    • Behavioral Neuroscience

    Background:

    • Dopamine beta-hydroxylase (DBH) inhibition affects neurotransmitter levels.
    • Triiodothyronine (T3) is a thyroid hormone influencing metabolism and neurological function.
    • Understanding drug interactions is crucial for predicting toxicological outcomes.

    Purpose of the Study:

    • To investigate the synergistic effects of FLA-63 and T3 on rat behavior.
    • To explore the potential mechanisms behind the observed behavioral changes.
    • To assess the role of hyperthyroidism in drug toxicity.

    Main Methods:

    • Rats were treated with FLA-63 (dopamine beta-hydroxylase inhibitor) and T3.
    • Behavioral suppression (bar pressing, activity, feeding) was monitored.

    Related Experiment Videos

  • Comparison with diethyldithiocarbamate effects was performed.

    • Main Results:

    • T3 synergistically potentiated FLA-63-induced behavioral suppression.
    • The combined effect mimicked higher doses of FLA-63 alone.
    • T3 did not potentiate depression induced by diethyldithiocarbamate.
    • Behavioral changes were attributed to increased FLA-63 toxicity.

    Conclusions:

    • T3 potentiates FLA-63 toxicity, particularly in a hyperthyroid state.
    • The interaction suggests a complex interplay between thyroid hormones and catecholamine synthesis inhibition.
    • Findings highlight the importance of considering hormonal status in drug safety assessments.